Randomized, Blinded, Single-arm Intradermal Injection, Control of Similar Products on the Market, the Safety Pre-evaluation Phase I Clinical Trial of BCG-PPD in Healthy People
Latest Information Update: 23 Feb 2022
Price :
$35 *
At a glance
- Drugs BCG-PPD (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Diagnostic use
- Sponsors Anhui Zhifei Longcom Biopharmaceutical
- 21 Feb 2022 Status changed from recruiting to completed.
- 04 Jun 2021 Planned End Date changed from 1 Feb 2021 to 1 Jul 2021.
- 10 Dec 2020 Planned primary completion date changed from 1 Dec 2020 to 1 Feb 2021.